Research Topics
| K F AdamsSummaryAffiliation: University of North Carolina Country: USA Publications
| Collaborators
|
Detail Information
Publications
Patients with mild heart failure worsen during withdrawal from digoxin therapyK F Adams
Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
J Am Coll Cardiol 30:42-8. 1997..We investigated whether patients with mild heart failure due to left ventricular systolic dysfunction were at risk of worsening during digoxin withdrawal...
Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failureKirkwood F Adams
Division of Cardiology, Heart Failure Program, School of Medicine, University of North Carolina, 6110 Falconbridge Road, Suite 101, Chapel Hill, NC 27517, USA
Am J Health Syst Pharm 61:S4-13. 2004..The pathophysiology of heart failure is reviewed, with particular focus on the role of abnormal neurohormonal activation of the sympathetic nervous system and the renin-angiotensin-aldosterone axis in the pathophysiology of this syndrome...
B-type natriuretic peptide: from bench to bedsideKirkwood F Adams
Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7075, USA
Am Heart J 145:S34-46. 2003
Systems biology and heart failure: concepts, methods, and potential research applicationsKirkwood F Adams
UNC Heart Failure Program, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA
Heart Fail Rev 15:371-98. 2010....
Biomarker guided therapy for heart failure: focus on natriuretic peptidesKirkwood F Adams
Department of Medicine, School of Medicine, UNC Heart Failure Program, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA
Heart Fail Rev 15:351-70. 2010..Although pilot work has provided encouraging results, appropriately designed, large-scale, prospective randomized trials are needed to confirm these preliminary findings and definitively establish this therapeutic approach...
Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) RegistryKirkwood F Adams
Department of Medicine and Radiology, School of Medicine, University of North Carolina at Chapel Hill, NC 27514, USA
Am Heart J 157:926-32. 2009..Although a potentially important pathophysiologic factor in heart failure, the prevalence and predictors of anemia have not been well studied in unselected patients with heart failure...
Clinical predictors of in-hospital mortality in acutely decompensated heart failure-piecing together the outcome puzzleKirkwood F Adams
Department of Medicine, School of Medicine, University of North Carolina Heart Failure Program, Chapel Hill, NC 27514, USA
Congest Heart Fail 14:127-34. 2008..1% to 21.9%. Although risk stratification alone cannot improve outcomes, identification of patients at high and low risk may improve resource utilization and better focus the intensity of care according to outcome...
Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failureKirkwood F Adams
Department of Medicine and Radiology, University of North Carolina Chapel Hill, Chapel Hill, NC 27514, USA
Am Heart J 160:1142-8. 2010..We prospectively evaluated the relationship between this marker and hematopoietic disturbances in heart failure...
How should COMET influence heart failure practice?Kirkwood F Adams
The University of North Carolina at Chapel Hill Heart Failure Program, 6110 Falconbridge Road, Suite 101, Chapel Hill, NC 27517, USA
Curr Heart Fail Rep 1:67-71. 2004..Further studies are needed to determine whether there are additional clinical benefits from the inhibition of adrenergic receptors beyond the proven benefits of b1-blockade...
Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)Kirkwood F Adams
Division of Cardiology, University of North Carolina, Chapel Hill, NC, USA
Am Heart J 149:209-16. 2005..Most available data on these patients are limited by patient selection criteria and study design of clinical trials and single-center studies...
Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysisKirkwood F Adams
Department of Medicine and Radiology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27517, USA
J Am Coll Cardiol 46:497-504. 2005..The purpose of this study was to investigate the relationship of serum digoxin concentration (SDC) and outcomes in women with heart failure (HF)...
Are angiotensin-converting enzyme inhibitors and beta-blockers making an impact on the epidemiology of heart failure?Kirkwood F Adams
University of North Carolina Heart Failure Program, 6110 Falconbridge Road, Suite 101, Chapel Hill, NC 27517, USA
Curr Cardiol Rep 6:162-8. 2004..These agents are capable of substantially reducing the morbidity and mortality associated with heart failure. However, the importance of enhanced physician and public awareness of heart failure remains critical in the future...
Beta-blockers in heart failure: how far have we progressed?Kirkwood F Adams
University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599 7075, USA
Postgrad Med 112:7-15. 2002..Mechanistic and early clinical trials are reviewed, along with the results from CIBIS-II, MERIT-HF, and COPERNICUS. Barriers to the use of beta-blocker therapy also are discussed...
Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failureKirkwood F Adams
Department of Medicine and Radiology, University of North Carolina Chapel Hill, Chapel Hill, NC 27514, USA
Am Heart J 158:965-71. 2009..Reduced hemoglobin has been associated with adverse outcomes in heart failure, but the relationship of hemoglobin to health-related quality of life in outpatients with this syndrome has not been well studied...
Clinical predictors of worsening heart failure during withdrawal from digoxin therapyK F Adams
Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, 27599 7075, USA
Am Heart J 135:389-97. 1998....
Clinical benefits of low serum digoxin concentrations in heart failureKirkwood F Adams
Departments of Medicine and Radiology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599 7075, USA
J Am Coll Cardiol 39:946-53. 2002..We sought to determine whether there was a relationship between serum digoxin concentration (SDC), including SDCs typically regarded as low, and clinical efficacy related to digoxin in patients with symptomatic left ventricular dysfunction...
Angiotensin-converting enzyme inhibition and vascular remodeling in coronary artery diseaseK F Adams
Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill 27599 7075, USA
Coron Artery Dis 9:675-84. 1998....
Gender differences in survival in advanced heart failure. Insights from the FIRST studyK F Adams
University of North Carolina at Chapel Hill, 27599 7075, USA
Circulation 99:1816-21. 1999..This study investigates whether a similar survival advantage for women would be evident among patients with advanced heart failure...
Translating heart failure guidelines into clinical practice: clinical science and the art of medicineK F Adams
Division of Cardiology, University of North Carolina at Chapel Hill, CB 7075, Burnett Womack Building, Chapel Hill, NC 27599, USA
Curr Cardiol Rep 3:130-5. 2001..The recent guideline process for a specific chronic cardiovascular disease, heart failure, is used for illustration of the translation process...
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA InvestigatorsM R Bristow
Division of Cardiology, University of Colorado HSC, Denver 80262, USA
Circulation 94:2807-16. 1996..We conducted a multicenter, placebo-controlled trial designed to establish the efficacy and safety of carvedilol, a "third-generation" beta -blocking agent with vasodilator properties, in chronic heart failure...
Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failureWendy A Gattis
Duke University Medical Center Duke Clinical Research Institute, Division of Cardiology, Durham, North Carolina 27705, USA
Am J Cardiol 91:169-74. 2003..These results also suggest that caution should be taken when withdrawing beta blockade in this population...
Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?Michael R Bristow
Division of Cardiology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
J Card Fail 9:444-53. 2003....
Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failureLarry A Allen
Division of Cardiology, University of Colorado Denver, Aurora, CO, USA
J Card Fail 16:230-8. 2010..Our study sought to validate the prognostic value of RDW in heart failure and to explore the potential mechanisms underlying this association...
Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF)Mihai Gheorghiade
Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Ill 60611, USA
Am Heart J 145:S55-7. 2003
Effect of fluoxetine on carvedilol pharmacokinetics, CYP2D6 activity, and autonomic balance in heart failure patientsD W Graff
Division of Pharmacotherapy, University of North Carolina School of Pharmacy, Chapel Hill, NC 27599-7360, USA
J Clin Pharmacol 41:97-106. 2001..However, this interaction was of little clinical significance in our sample population...
New epidemiologic perspectives concerning mild-to-moderate heart failureK F Adams
Departments of Medicine and Radiology, School of Medicine, University of North Carolina at Chapel Hill, 27599-7075, USA
Am J Med 110:6S-13S. 2001..These data highlight the importance of enhancing physician and public awareness of heart failure. New methods of molecular epidemiology will point toward better and earlier detection of this common and frequently fatal condition...
The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF)Mihai Gheorghiade
Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
Am J Cardiol 96:18G-25G. 2005..Accordingly, therapies for AHFS that are aimed at improving hemodynamics may affect long-term prognosis by either injuring or salvaging myocardium...
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trialMichael S Cuffe
Northwestern University Medical School, Division of Cardiology, 201 E Huron St, Galter 10 240, Chicago, IL 60611, USA
JAMA 287:1541-7. 2002..Although intravenous inotropic therapy usually produces beneficial hemodynamic effects and is labeled for use in the care of such patients, the effect of such therapy on intermediate-term clinical outcomes is uncertain...
Independent prognostic value of echocardiography and N-terminal pro-B-type natriuretic peptide in patients with heart failureAlan L Hinderliter
Division of Cardiology, University of North Carolina, Chapel Hill, NC 27559 7075, USA
Am Heart J 156:1191-5. 2008..Whether cardiac ultrasound and natriuretic peptides provide independent prognostic information is uncertain...
The COMET trialMichael R Bristow
Division of Cardiology, University of Colorado Health Sciences Center, B130, Room 6430, 4200 East Ninth Avenue, Denver, CO 80262, USA
Congest Heart Fail 11:39-47. 2005
Relationship of depression to death or hospitalization in patients with heart failureAndrew Sherwood
Department of Psychiatry, Duke University Medical Center, Durham, NC, USA
Arch Intern Med 167:367-73. 2007..However, patients with heart failure (HF) have been less frequently studied, and the effect of depression on prognosis, independent of disease severity, is uncertain...
Survival rates are similar between African American and white patients with heart failureStephanie H Dunlap
Department of Medicine, School of Medicine, University of Illinois at Chicago, Chicago, Ill, USA
Am Heart J 146:265-72. 2003..21 (95% CI, 0.80-1.84; P =.367). CONCLUSION: African American and white patients with symptomatic heart failure had similar survival rates in our database...
Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the Randomized Intravenous Tezosentan study (RITZ-4)CHRISTOPHER M O'CONNOR
Duke University Medical Center and Duke Clinical Research Institute, Durham, University of North Carolina, Chapel Hill, NC 27705, USA
Am Heart J 144:583-8. 2002..Tezosentan is a dual endothelin receptor antagonist, and it has improved cardiac output and reduced pulmonary and systemic vascular resistance in experimental animal models and in initial human acute decompensated heart failure studies...
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trialMihai Gheorghiade
Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Ill 60611, USA
JAMA 291:1963-71. 2004..In contrast to diuretics, the vasopressin antagonist tolvaptan may increase net volume loss in heart failure without adversely affecting electrolytes and renal function...
Surrogate end points in heart failureCraig R Lee
School of Pharmacy, Division of Pharmacotherapy, University of North Carolina at Chapel Hill, 27599-7360, USA
Ann Pharmacother 36:479-88. 2002..Further investigation of these measures is required before routine implementation in drug development and clinical practice can be justified...
Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failureMihai Gheorghiade
Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Ill 60611, USA
Am Heart J 145:S51-4. 2003
Digoxin in the management of cardiovascular disordersMihai Gheorghiade
Division of Cardiology, Northwestern University Feinberg School of Medicine, Galter 10-240, 201 East Huron St, Chicago, Ill 60611-2908, USA
Circulation 109:2959-64. 2004
Early worsening heart failure in patients admitted with acute heart failure--a new outcome measure associated with long-term prognosis?Beth Davison Weatherley
Momentum Research Inc, Durham, NC, USA
Fundam Clin Pharmacol 23:633-9. 2009..7-6.3). Early WHF is a common adverse event in patients admitted with AHF, and is associated with AHF severity and excessive 6-month mortality. WHF should be considered as a clinically important endpoint in AHF studies...
Vasopressin: a new target for the treatment of heart failureCraig R Lee
School of Pharmacy, University of North Carolina at Chapel Hill, 27599-7075, USA
Am Heart J 146:9-18. 2003....
Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failureMaximilian T Lobmeyer
Department of Pharmacy Practice, University of Florida, Gainesville, FL 32610, USA
Pharmacogenet Genomics 17:277-82. 2007..We tested whether the ADRA2C insertion/deletion polymorphism was associated with beta-blocker response in heart failure, either alone or in combination with the ADRB1Arg389Gly polymorphism...
Surrogate end points in heart failure trialsMihai Gheorghiade
Northwestern University, Feinberg School of Medicine, Chicago, Ill 60611, USA
Am Heart J 145:S67-70. 2003
Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trialWilson S Colucci
Cardiovascular Medicine, Boston University Medical Center, 88 E Newton St, Boston, MA 02118, USA
Circulation 116:49-56. 2007..We investigated whether beta-blocker therapy ameliorates left ventricular remodeling in asymptomatic patients with left ventricular systolic dysfunction...
Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapyLeonardo De Luca
Department of Cardiovascular Sciences, Laboratory of Interventional Cardiology, European Hospital, Rome, Italy
Heart Fail Rev 12:97-104. 2007....
Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) studyGerasimos Filippatos
Department of Cardiology, Athens University, Athens, Greece
J Card Fail 13:360-4. 2007..The association between baseline blood urea nitrogen (BUN) and clinical outcomes in patients admitted for ADHF was evaluated in a post-hoc analysis of the ACTIV in CHF trial...
Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial)Wendy A Gattis
Duke Clinical Research Institute, Duke University Medical Center, 2400 N Pratt Street, Box 17969, Durham, NC 27710, USA
Am J Cardiol 93:1436-7, A10. 2004..One hundred ninety-two patients were enrolled in this study. Patients with baseline cTnI values were included in this analysis, and the relation between cTnI and the composite clinical primary end point of RITZ-4 was evaluated...
Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trialVic Hasselblad
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
Eur J Heart Fail 9:1064-9. 2007..We examined the relation of maximal in-hospital diuretic dose to weight loss, changes in renal function, and mortality in hospitalised heart failure (HF) patients...
The pathophysiology of acute heart failure--is it all about fluid accumulation?Gad Cotter
Duke University Medical Center, The Duke Clinical Research Institute, Durham, NC 27715, USA
Am Heart J 155:9-18. 2008....
Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trialManuela Zampino
Northwestern University, Feinberg School of Medicine, Chicago, Ill 60611, USA
Am Heart J 145:S62-6. 2003
The problem of decompensated heart failure: nomenclature, classification, and risk stratificationG Michael Felker
Duke Clinical Research Institute, Durham, NC 27705, USA
Am Heart J 145:S18-25. 2003..It also defines the current understanding of strategies for risk stratification in the setting of decompensated heart failure...
Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failureMonica R Shah
Duke Clinical Research Institute, P O Box 17969, Durham, NC 27715, USA
Eur J Heart Fail 4:297-304. 2002..Changes in hemodynamic measures often serve as surrogate end points in efficacy trials for advanced heart failure, although there are few objective data to support this practice...
Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4)Wendy A Gattis
Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina 27705, USA
J Am Coll Cardiol 41:1452-7. 2003..Tezosentan did not demonstrate pro-ischemic effects in this population. Symptomatic hypotension may have resulted in an increased number of adverse events in the treatment group. Further studies with lower tezosentan doses are warranted...
Hospitalizations due to unstable angina pectoris in diastolic and systolic heart failureAli Ahmed
University of Alabama at Birmingham, Alabama, USA
Am J Cardiol 99:460-4. 2007..As in patients with systolic HF, those with diastolic HF should be routinely evaluated for myocardial ischemia and managed accordingly...
Risk stratification after hospitalization for decompensated heart failureG Michael Felker
Duke Clinical Research Institute, 2400 Pratt Street, Room 0311, Terrace Level, Durham, NC 27705, USA
J Card Fail 10:460-6. 2004..Further research into the validity of this model in independent samples will potentially aid in the development of risk stratification strategies...
Gender differences in advanced heart failure: insights from the BEST studyJalal K Ghali
Cardiac Centers of Louisiana, Shreveport, Louisiana 71103, USA
J Am Coll Cardiol 42:2128-34. 2003..The goal of this study was to determine the influence of gender on baseline characteristics, response to treatment, and prognosis in patients with heart failure (HF) and impaired left ventricular ejection fraction (LVEF)...
beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failureSteven G Terra
Department of Pharmacy Practice, University of Florida, Gainsville, FL 32610, USA
Clin Pharmacol Ther 77:127-37. 2005..We also tested whether polymorphisms in the beta(2)-adrenergic receptor, G-protein alpha s subunit (G(s)alpha), and cytochrome P450 (CYP) 2D6 genes or S-metoprolol plasma concentrations were associated with beta-blocker tolerability...
Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failureG Michael Felker
Duke Clinical Research Institute, Durham, North Carolina 27715, USA
Am J Cardiol 92:625-8. 2003..Lower baseline hemoglobin is associated with risk of short-term adverse clinical outcomes in this population, even after controlling for other baseline differences...
Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapySteven G Terra
Department of Pharmacy Practice, University of Florida College of Pharmacy, Gainesville, FL 32610, USA
Pharmacogenet Genomics 15:227-34. 2005..We hypothesized that polymorphisms at codon 389 (Arg389Gly) and 49 (Ser49Gly) in the beta1-adrenergic receptor (AR) gene were associated with LV reverse remodeling changes in response to beta-blocker therapy among heart failure patients...
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) sLiviu Klein
Northwestern University Feinberg School of Medicine, Chicago, Ill 60611, USA
Circulation 111:2454-60. 2005..CONCLUSIONS: In patients hospitalized for worsening heart failure, admission serum sodium is an independent predictor of increased number of days hospitalized for cardiovascular causes and increased mortality within 60 days of discharge...
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)William T Abraham
Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio, USA
J Am Coll Cardiol 46:57-64. 2005..We sought to compare the in-hospital mortality of patients with acute decompensated heart failure (ADHF) who were receiving parenteral treatment with one of four intravenous vasoactive medications...
Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysisGregg C Fonarow
Ahmanson UCLA Cardiomyopathy Center, University of California, Los Angeles Medical Center, Los Angeles, CA 90095, USA
JAMA 293:572-80. 2005..Estimation of mortality risk in patients hospitalized with acute decompensated heart failure (ADHF) may help clinicians guide care...
Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure TrialInder S Anand
VA Medical Center, Minneapolis, Minnesota, USA
J Am Coll Cardiol 49:32-9. 2007....
Acute heart failure associated with high admission blood pressure--a distinct vascular disorder?Olga Milo-Cotter
Duke University Medical Center and the Duke Clinical Research Institute, Durham NC, 27515, USA
Eur J Heart Fail 9:178-83. 2007..Although blood pressure (BP) is elevated in patients with acute heart failure (AHF), first admission BP has not been meticulously recorded before treatment in previous studies...
Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trialAli Ahmed
University of Alabama at Birmingham, 1530 3rd Ave S, CH 19, Suite 219, Birmingham AL 35294 2041, USA
Circulation 114:397-403. 2006..Although digoxin was tested in an appreciable number of diastolic heart failure patients in the Digitalis Investigation Group ancillary trial, detailed findings from this important study have not previously been published...
Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fractionFrancois Alla
Department of Epidemiology, University Hospital of Nancy, Nancy, France
Am Heart J 153:1074-80. 2007..Whether women with chronic heart failure are at less risk for hospitalization for worsening heart failure has not been well investigated...
Beta-blocker use and outcomes among hospitalized heart failure patientsJaved Butler
Cardiovascular Medicine Division, Vanderbilt University, Nashville, Tennessee, USA
J Am Coll Cardiol 47:2462-9. 2006....
Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trialAli Ahmed
University of Alabama at Birmingham, VA Medical Center, 1530 3rd Avenue South, CH 19, Ste 219, Birmingham, AL 35294 2041, USA
Eur Heart J 27:178-86. 2006..To determine the effects of digoxin on all-cause mortality and heart failure (HF) hospitalizations, regardless of ejection fraction, accounting for serum digoxin concentration (SDC)...
Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trialJoseph Rossi
Feinberg School of Medicine Northwestern University, Chicago, Illinois 60611, USA
Acute Card Care 9:82-6. 2007..Hyponatremia predicts poor outcome in patients with acute heart failure syndromes. This study evaluated the relationship between baseline serum sodium, change in serum sodium, and 60-day mortality in hospitalized heart failure patients...
Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4)Wendy A Gattis
Duke University Medical Center and Duke Clinical Research Institute, Durham, NC 27705, USA
Am Heart J 145:S58-9. 2003
Hyponatraemia in acute heart failure is a marker of increased mortality but not when associated with hyperglycaemiaOlga Milo-Cotter
Momentum Research, Inc, Durham, NC 27707, USA
Eur J Heart Fail 10:196-200. 2008..Although diabetes is a common co-morbidity in heart failure, no prior study has considered the impact of serum glucose on this relationship...
Anemia as a risk factor and therapeutic target in heart failureG Michael Felker
Duke Clinical Research Institute, Durham, North Carolina 27715, USA
J Am Coll Cardiol 44:959-66. 2004..Multiple ongoing studies will provide definitive data on the balance of risks and benefits of anemia treatment in chronic HF...
Design considerations and proposed template for clinical trials in hospitalized patients with decompensated chronic heart failureWendy A Gattis
Duke University Medical Center, Durham, NC 27705, USA
Am Heart J 145:S47-50. 2003
